Home
>
US Stocks
>
Cerus Corp.
Cerus Corp.
CERS

Cerus Corp. (CERS)

$6.230.16%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$6.17
Today Low/High
$6.17 / $6.32
52 Week Low/High
$4.67 / $8.87
P/E ratio
-17.4598
Market Cap
$1.07B

Company Details

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.
Organisation
Cerus Corp.
Headquaters
Concord, California, US
Employees
266
Industry
Health Technology
CEO
William Greenman

Discover more

Frequently Asked Questions

What is Cerus Corp. (CERS) share price today?

Can Indians buy Cerus Corp. (CERS) shares?

How can I buy Cerus Corp. (CERS) shares from India?

Can Fractional shares of Cerus Corp. (CERS) be purchased?

What are the documents required to start investing in Cerus Corp. (CERS) stocks?

We are a SEBI registered investement advisor